What are the management issues for hepatitis C in dialysis patients?: natural history of hepatitis C in dialysis populations

Semin Dial. 2014 Sep-Oct;27(5):446-8. doi: 10.1111/sdi.12292.

Authors

Andres F Carrion¹, Paul Martin

Affiliation

¹ Department of Medicine, Division of Hepatology, University of Miami Miller School of Medicine, Miami, Florida.

PMID: 25204876
DOI: 10.1111/sdi.12292

No abstract available

MeSH terms

Antiviral Agents / therapeutic use
Asymptomatic Diseases
Carcinoma, Hepatocellular / complications
Hepatitis C / complications*
Hepatitis C / drug therapy*
Heterocyclic Compounds, 3-Ring / therapeutic use
Humans
Kidney Transplantation
Liver Cirrhosis / complications
Liver Neoplasms / complications
Renal Dialysis
Renal Insufficiency, Chronic / complications*
Renal Insufficiency, Chronic / therapy
Simeprevir
Sofosbuvir
Sulfonamides / therapeutic use
Uridine Monophosphate / analogs & derivatives
Uridine Monophosphate / therapeutic use

Substances

Antiviral Agents
Heterocyclic Compounds, 3-Ring
Sulfonamides
Simeprevir
Uridine Monophosphate
Sofosbuvir